Screening of thiopurine S-methyltransferase mutations by horizontal conformation-sensitive gel electrophoresis

Human Mutation

Volumn 15, Issue 3, 2000, Pages 246-253

  Alves, Sandra ^a   Prata, Maria João ^a   Ferreira, Fátima ^b   Amorim, António ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b Unit of Reproductive Medicine Department of Gynecology Hospital Centre of S John Porto   (Portugal)

Author keywords

Drug metabolising enzyme; Horizontal conformation sensitive gel electrophoresis (HCSGE); Leukemia; Polymorphism; Thiopurine S methyltransferase (TPMT)

Indexed keywords

THIOPURINE METHYLTRANSFERASE;

ALLELE; ARTICLE; DNA POLYMORPHISM; EXON; GEL ELECTROPHORESIS; GENE FREQUENCY; GENE MUTATION; HUMAN; INTRON; NUCLEIC ACID BASE SUBSTITUTION; PORTUGAL; PRIORITY JOURNAL;

EID: 0034050713     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-1004(200003)15:3<246::aid-humu5>3.0.co;2-%23     Document Type: Article

References (22)

1. Alves S, Prata MJ, Ferreira F, Amorim A. 1999. Thiopurine methyltransferase: alternative molecular diagnosis and preliminary data from North Portugal. Pharmacogenetics 9:257-261.
2. Ameyaw MM, Collie-Duguid ES, Powrie RH, Ofori-Adjei D, Mcleod HL. 1999. Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet 8:367-370.
3. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. 1991. Analysis of the VNTR locus DIS80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 48:7-14.
4. Ganguly A and Prockop DJ. 1995. Detection of mismatched bases in double stranded DNA by gel electrophoresis. Electrophoresis 16:1830-1835.
5. Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE. 1999. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genetics 8(2):371-376.
6. Iyer L, Ratain MJ. 1998. Pharmacogenetics and cancer chemotherapy. Eur J Cancer 34(10):1493-1499.
7. Krynetski EY, Schuetz JD, Galpin AJ, Pui C-H, Relling MV Evans WE. 1995. A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci USA 92:949-953.
8. Lennard L, Van Loon JA, Weinshilboum RM. 1989. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 46:149-154.
9. Lennard L, Lylleyman JS, Van Loon JA, Weinshilboum RM. 1990. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia. Lancet 336:225-229.
10. McLeod HL, Lin JS, Scott EP, Pui CH, Evans WE. 1994. Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 55:15-20.
11. McLeod HL, Relling MV, Liu Q, Pui CH, Evans WE. 1995. Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood 85:1897-1902.
12. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res 16:1215.
13. Otterness D, Szumlanski C, Lennard L, Klemetsdal B, Aarbakke J, Park-Hah JO, Iven H, Schmiegelow K, Branum E, O'Brien J, Weinshilboum R. 1997. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther 62:60-73.
14. Otterness DM, Szumlanski CL, Wood TC, Weinshilboum RM. 1998. Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity. J Clin Invest 101: 1036-1044.
15. Raymond M, Rousset F. 1995. Genepop (version 1.2): population genetics for exact tests and ecumenicism. J Hered 86:248-249.
16. Spire-Vayron de la Moureyre C, Debuysere H, Sabbagh N, Marez D, Vinner E, Chevalier ED, Lo Guidice JM, Broly F. 1998a. Detection of know and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis. Hum Mutat 12:177-185.
17. Spire-Vayron de la Moureyre C, Debuysere H, Mastin B, Vinner E, Marez D, Lo Guidice JM, Chevalier D, Brique S, Motte K, Colombel JF, Turck D, Noel C, Flipo RM, Pol A, Lhermitte M, Lafitte JJ, Libersa C, Broly F. 1998b. Genotypic and phenotypic analysis of the thiopurine S-methyltransferase gene (TPMT) in a European population. Br J Pharmacol 125:879-887.
18. Tai HL, Krynetski EY, Yates CR, Loennechen T, Fessing MY, Krynetskaia NF, Evans E. 1996. Thiopurine S-methyltransterase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet 58:694-702.
19. Tan BB, Lear JT, Gawkrodger DJ, English JS. 1997. Azathioprine in dermatology: a survey of current practice in the UK. Br J Dermatol 136:351-355.
20. Weinshilboum RM, Sladek SL. 1980. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32:651-662.
21. Willman CL. 1998. Molecular genetic features of myelodysplasic syndromes (MDS). Leukemia 12(1):S2-S6.
22. Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE. 1997. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 126:608-614.